Kristen K Ciombor

Kristen K Ciombor

UNVERIFIED PROFILE

Are you Kristen K Ciombor?   Register this Author

Register author
Kristen K Ciombor

Kristen K Ciombor

Publications by authors named "Kristen K Ciombor"

Are you Kristen K Ciombor?   Register this Author

30Publications

1206Reads

39Profile Views

Promising New Agents for Colorectal Cancer.

Curr Treat Options Oncol 2018 05 11;19(6):29. Epub 2018 May 11.

West Virginia University Cancer Institute, P.O. Box 9300, 1801 HSS, 1 Medical Center Drive, Morgantown, WV, 26506, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-018-0543-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499928PMC
May 2018

Hypermutated Tumors and Immune Checkpoint Inhibition.

Drugs 2018 Feb;78(2):155-162

West Virginia University Cancer Institute, P.O. Box 9300, 1801 HSS, 1 Medical Center Drive, Morgantown, WV, 26506, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-018-0863-0DOI Listing
February 2018

A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer.

Oncologist 2018 01 11;23(1):25-34. Epub 2017 Oct 11.

Division of Hematology and Medical Oncology, Department of Internal Medicine, Mayo Clinic Cancer Center, Phoenix, Arizona, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759820PMC
January 2018

Primary Tumor Sidedness as Prognostic and Predictive Biomarker in Metastatic Colorectal Cancer: Further Validation of a Potentially Practice-Changing Variable.

JAMA Oncol 2017 Feb;3(2):165-166

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3777DOI Listing
February 2017

Diagnosis and Diagnostic Imaging of Anal Canal Cancer.

Surg Oncol Clin N Am 2017 01;26(1):45-55

Department of Radiology, The Royal Marsden NHS Foundation Trust and Imperial College London, Downs Road, Sutton, Surrey SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2016.07.002DOI Listing
January 2017

Highlights in Gastrointestinal (Colorectal) Cancer Treatment: The Primary Tumor Sidedness Debate and Advances in Immunotherapy.

JAMA Oncol 2016 Dec;2(12):1537-1538

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3642DOI Listing
December 2016

Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.

Sci Rep 2016 09 14;6:33273. Epub 2016 Sep 14.

University of Miami Miller School of Medicine, Division of Biostatistics, Department of Public Health Sciences, Miami, 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep33273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021945PMC
September 2016

Genomic diversity of colorectal cancer: Changing landscape and emerging targets.

World J Gastroenterol 2016 Jul;22(25):5668-77

Daniel H Ahn, Tanios Bekaii-Saab, Division of Medical Oncology, Mayo Clinic, Phoenix, AZ 85054, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i25.5668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932204PMC
July 2016

Update on Anti-Angiogenesis Therapy in Colorectal Cancer.

Curr Colorectal Cancer Rep 2015 Dec;11(6):378-387

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11888-015-0292-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991548PMC
December 2015

Recent therapeutic advances in the treatment of colorectal cancer.

Annu Rev Med 2015 9;66:83-95. Epub 2014 Oct 9.

The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210; email: , ,

View Article

Download full-text PDF

Source
http://www.annualreviews.org/doi/10.1146/annurev-med-051513-
Publisher Site
http://dx.doi.org/10.1146/annurev-med-051513-102539DOI Listing
September 2015

Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.

Cancer Res 2014 Dec 15;74(23):6947-57. Epub 2014 Oct 15.

Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee. Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. Department of Cell and Development Biology, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-1592DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252979PMC
December 2014

How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

Curr Colorectal Cancer Rep 2014 Dec;10(4):372-379

Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11888-014-0244-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226466PMC
December 2014

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group.

Invest New Drugs 2014 Oct 4;32(5):1017-27. Epub 2014 Jun 4.

Division of Medical Oncology, Department of Internal Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, A445A Starling Loving Hall, 320 West 10th Avenue, Columbus, OH, 43212, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-014-0111-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171216PMC
October 2014

Targeting metastatic colorectal cancer - present and emerging treatment options.

Pharmgenomics Pers Med 2014 8;7:137-44. Epub 2014 Jul 8.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PGPM.S47582DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100688PMC
July 2014

Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer.

Hepat Oncol 2014 Jun 9;1(3):331-345. Epub 2014 Sep 9.

Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210-1280, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/hep.14.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095158PMC
June 2014

Aflibercept--a decoy VEGF receptor.

Curr Oncol Rep 2014 Feb;16(2):368

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, A445A Starling Loving Hall, 320 West 10th Avenue, Columbus, OH, 43210, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0368-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145308PMC
February 2014

Current therapy and future directions in biliary tract malignancies.

Curr Treat Options Oncol 2013 Sep;14(3):337-49

, 2220 Pierce Avenue, 777 Preston Research Building, Nashville, TN, 37232, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-013-0237-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769474PMC
September 2013

Aflibercept.

Clin Cancer Res 2013 Apr 26;19(8):1920-5. Epub 2013 Feb 26.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710732PMC
April 2013

Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.

Am J Clin Oncol 2012 Oct;35(5):446-50

Division of Hematology-Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31821862fbDOI Listing
October 2012

Transfusion medicine illustrated. Profound piperacillin-mediated drug-induced immune hemolysis in a patient with cystic fibrosis.

Transfusion 2012 Jan 27;52(1):4-5. Epub 2011 Oct 27.

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1537-2995.2011.03407.x
Publisher Site
http://dx.doi.org/10.1111/j.1537-2995.2011.03407.xDOI Listing
January 2012